TLR9 and bacterial infectious disease: Previously, our laboratory has demonstrated the utility and effectiveness of intranasal delivery of potent innate immune activators such as liposome-TLR9 complexes for prevention of mortality due to lethal viral or bacterial infections [21] [22] [23] [24] [25] [26] [27] [28] [29].